Cardiovascular & Hematological Disorders-Drug Targets
Title:Preface
Volume: 16 Issue: 1
Author(s): Garry Shen
Affiliation:
Export Options
About this article
Cite this article as:
Shen Garry, Preface, Cardiovascular & Hematological Disorders-Drug Targets 2016; 16 (1) . https://dx.doi.org/10.2174/1871529X1601161021165238
DOI https://dx.doi.org/10.2174/1871529X1601161021165238 |
Print ISSN 1871-529X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4063 |
Related Journals
Related Books
39
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Contribution of Mast Cells to Cerebral Aneurysm Formation
Current Neurovascular Research Low Molecular Weight Heparin: Current Evidence for Its Application in Orthopaedic Surgery
Current Vascular Pharmacology Diabetic Cardiomyopathy and Oxidative Stress: Role of Antioxidants
Cardiovascular & Hematological Agents in Medicinal Chemistry Hypoxia Signaling and the Metastatic Phenotype
Current Molecular Medicine Renal and Cardiac Effects of Renal Sympathetic Denervation and Carotid Baroreceptor Stimulation
Current Vascular Pharmacology Prostaglandins and Cyclooxygenases in Glial Cells During Brain Inflammation
Current Drug Targets - Inflammation & Allergy Subcellular Analysis of the Platelet Proteome
Current Proteomics Anti-annexin A5, Antiphosphatidylinositol Antibodies, and Haematological Parameters in Preeclampsia Patients: A Case-Control Study
Current Women`s Health Reviews Progress and Promise of Nur77-based Therapeutics for Central Nervous System Disorders
Current Neuropharmacology Hypoxia Inducible Factor 1 as a Therapeutic Target in Ischemic Stroke
Current Medicinal Chemistry HMG-CoA Reductase Inhibitors: Effects on Chronic Subacute Inflammation and Onset of Atherosclerosis Induced by Dietary Cholesterol
Current Drug Targets - Cardiovascular & Hematological Disorders Natural and Nanotechnology Based Treatment: An Alternative Approach to Psoriasis
Current Nanomedicine Notch Signaling in Cardiovascular Disease and Calcification
Current Cardiology Reviews Angiotensin-Converting Enzyme Inhibitors: Mechanisms of Action and Implications In Anesthesia Practice
Current Pharmaceutical Design Herbal Drug use in Sickle Cell Disease Management; Trends and Perspectives in Sub-Saharan Africa - A Systematic Review
Current Drug Discovery Technologies Diabetes Beyond Insulin: Review of New Drugs for Treatment of Diabetes Mellitus
Current Drug Discovery Technologies Visnagin: A New Perspective of Medicinal Importance, Physiological Functions, Phytochemistry, Pharmacology and Analytical Aspects of Active Phytoconstituents of Ammi visnaga
The Natural Products Journal Carbon Monoxide and the Brain: Time to Rethink the Dogma
Current Pharmaceutical Design Lipoxygenase Inhibitors as Cancer Chemopreventives: Discovery, Recent Developments and Future Perspectives
Current Medicinal Chemistry Targeting Stress Activated Protein Kinases, JNK and p38, as New Therapeutic Approach for Neurodegenerative Diseases
Central Nervous System Agents in Medicinal Chemistry